Events

CPhI Worldwide in Frankfurt, 5th to 6th November 2019

Upperton will be exhibiting CPhI in Frankfurt this November, our stand will be located at the Department of International Trade (DIT) UK Pavilion stand 41H20 within CPhI Worldwide, Hall 4. Attending CPhI on behalf of Upperton are: Dr Richard Johnson the Founder & CEO, Paul Kelsall Director of Clinical Manufacturing, Dr Ian Lafferty Technical Consultant and Klara Fisken Business Development Associate.

Richard Johnson
Founder and CEO

Dr Richard Johnson founded Upperton Pharma Solutions in August 1999, and continues to play a key role in the management and strategic development of the company. With over 30 years of experience in the pharmaceutical, biotechnology and drug delivery fields, Richard previously held senior management positions at Andaris Limited (Vectura) and Delta Biotechnology (now Albumedix). Richard holds an honours degree in Biology from University of York and a Ph.D. from the University of Warwick and has a proven track record in successfully developing innovative pharmaceutical products from early feasibility studies through to commercial products.

Paul Kelsall
Director of Clinical Manufacturing

Paul has over 20 years of experience in the pharmaceutical industry, having previously worked for Boots, Reckitt Benckiser, Nova Laboratories and Aesica. Paul’s experience covers both Sterile and Non-Sterile Manufacturing, Formulation Development, Facilities Management and Business Improvement. Paul’s responsibilities include managing the Upperton Pharma Solutions Facility and all the GMP Operations that are conducted on site.

Ian Lafferty
Technical Consultant

Dr Ian Lafferty has recently joined Upperton Pharma Solutions as a Technical Consultant.  Ian has 25 years’ technical and operational experience in early phase pharmaceutical development encompassing the formulation design, development, process optimisation and manufacture of a wide range of dosage forms including oral solids, inhaled powders, suspensions and injectables with a focus on challenging molecules, enabling technologies and high potent handling.  He also has significant experience in facility design and management.

Ian has held senior roles at several emerging and growing CDMOs providing strategic and operational leadership to ensure excellence in all aspects of providing pharmaceutical services.

Klara Fisken
Business Development Associate

Klara Fisken joined Upperton in August 2018, after completing a three month project at Upperton which was part of her MSc in Applied Biopharmaceutical Biotechnology and Entrepreneurship from the University of Nottingham. Klara is responsible for Upperton’s marketing which includes newsletters, creating marketing materials, press releases, website and social media.